The Need For Publicly Funded Trials To Get Unbiased Comparative Effectiveness Data
Comparative effectiveness research was one of the hotly debated components of the Affordable Care Act. The pharmaceutical industry is marketing driven, with pharmaceutical companies spending more on marketing than they do on research and development. The need for a marketing edge can also drive drug development.
As illustrated by the discussion below of Gazyva and Nexium, drugs can be developed at higher doses than the drugs they are intended to replace. When the newer, higher-dose drugs are tested against the older, lower-dose drugs, the trials are intended to show that the newer, higher dose drugs are superior to the old...
Source: Health Affairs Blog - February 20, 2015 Category: Health Management Authors: Robert Bohrer Tags: All Categories Business of Health Care Comparative Effectiveness Innovation Pharma Policy Research Source Type: blogs
